Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.1c01682
Abstract: Several monoclonal antibodies targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) pathway have been used successfully in anticancer immunotherapy. Inherent limitations of antibody-based therapies remain, however, and alternative small-molecule inhibitors that can block the…
read more here.
Keywords:
molecule inhibitors;
small molecule;
degradation;
discovery ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.15643
Abstract: The receptor tyrosine kinase HER2 is associated with a number of human malignancies and is an important therapeutic target. The antibody‐drug conjugate trastuzumab emtansine (T‐DM1; Kadcyla®) is recommended as a first‐line treatment for patients with…
read more here.
Keywords:
internalization degradation;
her2;
trastuzumab;
dm1 ... See more keywords